You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Sagent Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?

SAGENT PHARMS has seventy-eight approved drugs.

There is one tentative approval on SAGENT PHARMS drugs.

Summary for Sagent Pharms

US Patents:	0
Tradenames:	62
Ingredients:	60
NDAs:	78

Drugs and US Patents for Sagent Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms Inc	NEOSTIGMINE METHYLSULFATE	neostigmine methylsulfate	SOLUTION;INTRAVENOUS	216542-002	Feb 17, 2023	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Sagent Pharms Inc	DESMOPRESSIN ACETATE	desmopressin acetate	INJECTABLE;INJECTION	204695-001	Aug 22, 2017	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Sagent Pharms	DOXORUBICIN HYDROCHLORIDE	doxorubicin hydrochloride	INJECTABLE;INJECTION	091495-001	Mar 18, 2013	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Sagent Pharms Inc	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	090583-004	Nov 27, 2015	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Sagent Pharms Inc	METHYLPREDNISOLONE ACETATE	methylprednisolone acetate	INJECTABLE;INJECTION	201835-002	Jun 27, 2018	AB	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Sagent Pharms Inc	AMIKACIN SULFATE	amikacin sulfate	INJECTABLE;INJECTION	203323-001	May 12, 2016	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.